Investigating pancreatic cystic neoplasms and their genetic factors
TBEL Project 2
This study is looking at a specific type of pancreatic cyst that can lead to cancer, and it’s trying to understand how changes in a gene called RNF43 might affect the growth of these cysts, which could help find better ways to diagnose and treat pancreatic cancer for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10922844 on NIH RePORTER |
What this research studies
This research focuses on pancreatic cystic neoplasms, particularly intraductal papillary mucinous neoplasms (IPMNs), which have a significant risk of developing into pancreatic cancer. The study aims to understand the role of the RNF43 gene in these neoplasms and how its mutations affect cancer progression. By using advanced mouse models and genetically engineered cell lines, researchers will explore the cellular mechanisms involved in IPMN development and the potential for targeted therapies. Patients may benefit from insights that could lead to improved diagnostic and treatment strategies for pancreatic cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic cystic neoplasms, particularly those with intraductal papillary mucinous neoplasms.
Not a fit: Patients without pancreatic cystic neoplasms or those with other unrelated conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic tools and targeted therapies for patients with pancreatic cystic neoplasms, potentially improving survival rates.
How similar studies have performed: Previous research has shown promising results in understanding genetic factors in pancreatic cancer, but this specific approach is relatively novel.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Maitra, Anirban — University of Tx Md Anderson Can Ctr
- Study coordinator: Maitra, Anirban
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.